Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate) -: A novel adjuvant inducing both strong CMI and antibody responses

被引:272
作者
Davidsen, J
Rosenkrands, I
Christensen, D
Vangala, A
Kirby, D
Perrie, Y
Agger, EM [1 ]
Andersen, P
机构
[1] Statens Serum Inst, Dept Infect Dis Immunol, Adjuvent Res, DK-2300 Copenhagen, Denmark
[2] Statens Serum Inst, Vaccine Dev, Adjuvant Res, DK-2300 Copenhagen, Denmark
[3] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2005年 / 1718卷 / 1-2期
关键词
adjuvant; immunomodulator; liposome; trehalose 6,6 '-dibehenate; dimethyldioctadecylammonium;
D O I
10.1016/j.bbamem.2005.10.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
incorporation of the glycolipid trehalose 6,6'-dibehenate (TDB) into cationic liposomes composed of the quaternary ammonium compound dimethyldioctadecylammonium (DDA) produce an adjuvant system which induces a powerful cell-mediated immune response and a strong antibody response, desirable for a high number of disease targets. We have used differential scanning calorimetry (DSC) to investigate the effect of TDB on the gel-fluid phase transition of DDA liposomes and to demonstrate that TDB is incorporated into DDA liposome bilayers. Transmission Electron Microscopy (TEM) and cryo-TEM confirmed that liposomes were formed when a lipid film of DDA containing small amounts of TDB was hydrated in an aqueous buffer solution at physiological pH. Furthermore, time development of particle size and zeta potential of DDA liposomes incorporating TDB during storage at 4 degrees C and 25 degrees C, indicates that TDB effectively stabilizes the DDA liposomes. Immunization of mice with the mycobacterial fusion protein Ag85B-ESAT-6 in DDA-TDB liposomes induced a strong, specific Th1 type immune response characterized by substantial production of the interferon-gamma cytokine and high levels of IgG2b isotype antibodies. The lymphocyte subset releasing the interferon-gamma was identified as CD4 T cells. (c) 2005 Published by Elsevier B.V.
引用
收藏
页码:22 / 31
页数:10
相关论文
共 39 条
[31]   IMMUNOTHERAPY OF AN ASCITIC RAT HEPATOMA WITH CORD FACTOR (TREHALOSE-6, 6'-DIMYCOLATE) AND SYNTHETIC ANALOGS [J].
PIMM, MV ;
BALDWIN, RW ;
POLONSKY, J ;
LEDERER, E .
INTERNATIONAL JOURNAL OF CANCER, 1979, 24 (06) :780-785
[32]   Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system [J].
Rosenkrands, I ;
Agger, EM ;
Olsen, AW ;
Korsholm, KS ;
Andersen, CS ;
Jensen, KT ;
Andersen, P .
INFECTION AND IMMUNITY, 2005, 73 (09) :5817-5826
[33]   Advances in vaccine adjuvants [J].
Singh, M ;
O'Hagan, D .
NATURE BIOTECHNOLOGY, 1999, 17 (11) :1075-1081
[34]   CORD FACTOR (ALPHA,ALPHA-TREHALOSE 6,6'-DIMYCOLATE) INHIBITS FUSION BETWEEN PHOSPHOLIPID-VESICLES [J].
SPARGO, BJ ;
CROWE, LM ;
IONEDA, T ;
BEAMAN, BL ;
CROWE, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (03) :737-740
[35]  
STANFIELD JP, 1973, LANCET, V1, P215
[36]   A Plasmodium falciparum GLURP-MSP3 chimeric protein;: expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies [J].
Theisen, M ;
Soe, S ;
Brunstedt, K ;
Follmann, F ;
Bredmose, L ;
Israelsen, H ;
Madsen, SM ;
Druilhe, P .
VACCINE, 2004, 22 (9-10) :1188-1198
[37]   CHARACTERIZATION OF SURFACTANT VESICLES AS POTENTIAL MEMBRANE MODELS - EFFECT OF ELECTROLYTES, SUBSTRATES, AND FLUORESCENCE PROBES [J].
TRAN, CD ;
KLAHN, PL ;
ROMERO, A ;
FENDLER, JH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1978, 100 (05) :1622-1624
[38]   EFFECT OF PARTICLE-SIZE ON COLLOID STABILITY OF BILAYER-COVERED POLYSTYRENE MICROSPHERES [J].
TSURUTA, LR ;
LESSA, MM ;
CARMONARIBEIRO, AM .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1995, 175 (02) :470-475
[39]   Counterion effects on colloid stability of cationic vesicles and bilayer-covered polystyrene microspheres [J].
Tsuruta, LR ;
CarmonaRibeiro, AM .
JOURNAL OF PHYSICAL CHEMISTRY, 1996, 100 (17) :7130-7134